Sylvester Comprehensive Cancer Center


Mark Soloway, M.D., third from left, received an award for his lifetime service to urologic oncology. Congratulating him were, from left, conference organizers Balakrishna Lokeshwar, Ph.D., and  Vinata Lokeshwar, Ph.D., conference sponsor Edwin Cevallos, M.D., Dean Pascal J. Goldschmidt, M.D., and Sylvester Director Stephen D. Nimer, M.D.

Inaugural Cancer Symposium Shares Research Findings


Three of the nation’s top cancer researchers — each targeting a different form of the disease — were the keynote speakers at the University of Miami Cancer Symposium “Cancer Prevention and Treatment,” held January 24 at the Lois Pope LIFE Center Auditorium. The symposium was organized under the auspices of the Sylvester Comprehensive Cancer Center and the Department of Urology.

Tan A. Ince, M.D., Ph.D.

Researchers Discover New Hormone Receptors to Target When Treating Breast Cancer


In a new study directed by Tan A. Ince, M.D., Ph.D., associate professor of pathology at the Miller School of Medicine and member of the Sylvester Comprehensive Cancer Center, researchers have developed a new breast cancer classification system that shifts the focus away from genetic mutations, a common approach of mainstream cancer research, but one that has been less effective than first imagined.

Karina Galoian, Ph.D., and H. Thomas Temple, M.D.

Study Identifies Novel Highlights for Sarcoma Research


Researchers at the Miller School, led by Karina Galoian, Ph.D., research associate professor of orthopaedics, have uncovered pathways linked to the genesis of chondrosarcoma, cancer of the cells that produce cartilage. The study, “Lost miRNA surveillance of Notch, IGFR pathway -- road to sarcomagenesis,” was published in the January issue of Tumor Biology.